BACKGROUND
Client
is a healthcare organization providing care to its patients. IMO has developed an enhancement product
known as IMO® Problem ÍITÐ
which incorporates linkages to and data from the National Library of Medicine’s
MeSH database, UMLS and SNOMED® CT. Client and IMO (collectively “The
Parties”) desire to enter into a non-exclusive relationship whereby Client
will license IMO’s intellectual property, described in Exhibit A, (the
"Service") to use as an integral part of Client’s eClinicalWorks’
Electronic Medical Record ("EMR") solution on end-users' computer
systems (the "Integrated Service") and make available the Integrated
Service to its client end-users ("End-Users"). Client acknowledges
that the current implementation level of the Service within the eClinicalWorks
EMR solution is limited to the Service ICD maps.
Client
has supplied certain registration information through www.e-imo.com (the “IMO
ONLINE website”), thereby signifying its intent to be bound by the terms of
this Agreement. Client also acknowledges and agrees to be bound by the IMO
ONLINE Terms and Conditions of Use and the IMO ONLINE Privacy Policy. In
consideration of the foregoing, the mutual covenants contained herein and other
good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties hereto, intending to be legally bound hereby,
agree as follows:
1. DEFINITIONS
Service- The Service is defined
as the IMO® Problem ÍITÐ portal described in Exhibit A to
be incorporated into the Integrated Service.
Integrated
Service – The
Integrated Service is defined as the eClinicalWorks EMR solution in which the
Service is implemented.
End-User – The End-User is defined as any person authorized
by Client to use the Integrated Service.
Provider – Provider is defined as
any applicable End-User authorized by Client under the terms of a "Provider
License" as defined by the eClinicalWorks EMR solution.
2. TERM
The initial three (3) year term
("Initial Term") of this Agreement will commence on the Effective
Date and will automatically renew for successive one (1) year periods
thereafter ("Renewal Terms"), unless prior written notice not to
renew is provided by either party not less than ninety (90) days prior to the
end of the then current term. Payment
for the Initial and Renewal Terms shall be made in accordance with the
specifications outlined in Schedule I. Notice
to IMO shall be provided at the address shown in Section 14.J. Notice to Client shall be provided
to the most recent registration address supplied by Client through the IMO
ONLINE website. The Initial Term and any
Renewal Terms are referred to herein as the "Term."
3. LICENSE
GRANT
IMO hereby
grants to Client a non-exclusive, non-transferable license to use the
Service worldwide (except where specifically noted) during the Term of this
Agreement in the manner contemplated by this Agreement; provided, Client
assumes all responsibility to assure that the Service is appropriate for the
systems and uses to which it is put.
This license shall include the right to: (i) copy the Service for use
and distribution by Client to End-Users, solely as permitted by this Agreement;
(ii) use the Service for internal purposes in a non-clinical setting for
backup, archival, support, testing, training and demonstration purposes; (iii)
install the Service for Client’s End-Users; (iv)
license/sublicense the Service to Client's End-Users; (v) market and
demonstrate the Service to End-Users or potential End-Users; and (vi) advise
End-Users or potential End-Users to the availability of the Service.
The Service is
for use by Client and its End-Users only as contemplated by this
Agreement. Client shall not, other
than as specifically contemplated by this Agreement, cause or permit others to
copy, duplicate, redistribute, loan, rent, retransmit, publish, license or
sublicense or otherwise transfer, or commercially exploit, the Service or the
Integrated Service, in whole or part. Client
shall not prepare derivative works or incorporate the Service, in whole or part,
in any other system or work or reverse engineer, decompile, disassemble,
decrypt, translate, alter, adapt or modify the Service or the Integrated
Service, in whole or part, other than as is specifically contemplated by this
Agreement.
4. RESPONSIBILITIES
Subject to the terms and conditions
stated herein, Client will comply with the provisions of this Section 4:
A. Demonstrate,
train, and support the Integrated Service to Client End-Users during
the term of this Agreement at its own expense.
B. If
applicable, identify IMO as the source and copyright holder of the Service. Further, Client agrees not to obscure the IMO
copyright notice in any instance.
C. Receive
Regulatory Updates (updates released by an applicable regulatory body) from a
third party and apply these Regulatory Updates to its internal databases on or
before the date the regulatory code sets become effective (i.e. April 1 and
October 1). Client is responsible for
ensuring that the information in its internal databases matches the regulatory
code set version of the Service, which IMO automatically updates for each
Regulatory Update.
D. Provide
timely payment of all fees as per Schedules I of this Agreement.
E. Provide
End-User documentation for the Integrated Service.
F. Provide
IMO with the total number of Providers of the Integrated Service and any updated
contact information as requested by this Agreement on a quarterly basis, either
through direct communication with IMO or through the IMO ONLINE website.
G. Be
responsible for all third-party license fees for software necessary to run the
Integrated Service except those fees that are provided as part of the Service.
H. Client
will establish the appropriate firewalls and security systems, such that the
Service is accessed only by defined End-Users and is not used in an
unauthorized manner.
5. USE
OF NAME
Except for
inclusion in IMO’s official customer list, IMO may not use Client’s name, trade
names, trademarks, or service-marks in any public announcement, news release,
advertising or promotional literature without Client’s express, prior
written consent.
6. INDEMNIFICATION
Client shall defend,
indemnify, and hold IMO and its officers, directors, parent company and agents
harmless from any claims, liabilities, obligations, judgments, causes of
actions, costs and expenses (including reasonable attorney’s fees) arising out
of (i) use of the Service by End-Users, (ii) the performance of this Agreement
by Client
or any of its agents, employees, or resellers, or (iii) Client's negligence; provided,
the foregoing indemnity shall not apply to claims covered under sections 9A, 9B
or caused by IMO’s gross negligence. IMO shall provide reasonable notice of any
claim to Client and permit Client to control the defense of any
claim.
7. OWNERSHIP
AND USE
This
Agreement pertains to the license of rights to use the Service, and does not
provide for the sale or other transfer of title. IMO has and shall have exclusive title to and
ownership of all of its products, including the Service and of all of its
sub-parts and components, and of all updates, modifications, alterations,
customizations, derivative works, revisions or enhancements thereof, and of all
software, source code, and trade secrets, and proprietary research, equations,
screens, techniques, methodology, analysis, programming or know-how thereof.
This shall include any modifications, alterations, customizations, derivative
works, revisions or enhancements made to the Service by IMO as part of this Agreement.
It is anticipated that Client may provide additional requests for
terms to be added to the Service. These additions, if approved by IMO for
inclusion in the Service, will be considered part of the derivative work and
shall be owned by IMO with all rights
assigned by Client to IMO.
Client
shall not be charged for this regular inclusion of term requests. Client will
have a perpetual, non-exclusive license to use, display or modify these
additional terms without the additional IMO content.
IMO’s independent auditors, reasonably agreeable to Client, will
be permitted to review the number of Providers reported by Client at
IMO’s expense upon reasonable advance notice to Client during regular business hours,
not to exceed one (1) audit per year. If an audit uncovers a discrepancy of
more than 10% in favor of IMO, Client shall reimburse IMO for the reasonable costs of the audit.
9.
INTELLECTUAL
PROPERTY INDEMNITY, WARRANTY DISCLAIMER AND LIABILITY LIMITATION
A.
Intellectual
Property Indemnity
IMO
will defend, indemnify and hold Client harmless against third party
claims, costs, liabilities, judgments, attorneys’ fees, settlements, and
penalties brought against Client to the extent based on an
allegation that the use of the Service under this Agreement infringes on a
United States patent, trademark or copyright of a third party, if IMO is
notified promptly by Client in writing of any such action
or allegation of infringement, and if IMO shall have sole control of the
defense of any such action and all negotiations for its settlement or
compromise (provided that Client will not be liable under any
settlement agreement unless Client consents thereto). IMO shall not have any obligation to Client
to the extent the alleged
infringement claim is (i) based on information incorporated into the Service by
Client
or (ii) the result of a modification or addition to the Service made by Client
or (iii) based upon the use of the Service in combination with any
program or equipment or any part thereof not furnished or approved by IMO.
B. Technical
Warranty
IMO represents that it has not included in the
Service any disabling devices such as devices that result in the electronic
recapture of programming, undocumented functions, passwords, keys, security
devices or trap doors, and any computer viruses. In the event that any computer instruction
(including, but not limited to, computer instructions commonly referred to as
trojan horses, anomalies, worms, self-destruct mechanisms, or time/logic bombs)
is, or is believed to be, embedded in the Service by IMO or at IMO’s direction,
IMO agrees to promptly inform Client of such fact or belief,
cooperate with Client, and both parties will use their reasonable efforts to
remove the instructions and mitigate against its effects.
IMO represents and warrants that upon the Effective
Date and extending for as long as Client remains continuously on
support, the Service will, without material
error, perform the functions set forth on Exhibit A when operated in accordance
with the documentation and in the environment for which IMO designed the
Service to operate. In the event of a breach of this warranty, IMO will
repair, replace, or pay for the cost of replacing the failing item of the
Service so that it does perform in accordance with such warranty. This warranty shall not apply if Client
or End-Users fail to use the Service according to professional standards. CLIENT’S RIGHTS UNDER THIS SUBPARAGRAPH CONSTITUTE
ITS SOLE AND EXCLUSIVE REMEDY AND IMO’S SOLE AND EXCLUSIVE OBLIGATIONS WITH
RESPECT TO ANY BREACH OF THIS WARRANTY.
C. Warranty Disclaimer
CLIENT ACKNOWLEDGES THAT EXCEPT AS SPECIFICALLY PROVIDED IN
SECTIONS 9A AND 9B, THE SERVICE IS PROVIDED ON AN "AS IS" BASIS AND
IMO MAKES NO REPRESENTATION OR WARRANTY WHATSOEVER, EXPRESS OR IMPLIED, AS TO
THE ACCURACY OR NATURE OF THE DATA FROM WHICH THE SERVICE IS COMPILED, THE
MERCHANTABILITY AND FITNESS OF THE SERVICE FOR CLIENT’S PARTICULAR PURPOSE, OR
THE COMPATIBILITY OF THE SERVICE WITH CLIENT’S HARDWARE AND SYSTEMS.
IN ADDITION, WITHOUT LIMITING THE FOREGOING, THE SERVICE
HAS BEEN DESIGNED FOR USE IN THE UNITED STATES ONLY AND COVERS DRUG PRODUCTS
USED IN PRACTICE IN THE UNITED STATES. IMO PROVIDES NO CLINICAL INFORMATION OR
CHECKS FOR DRUGS NOT AVAILABLE FOR SALE IN THE UNITED STATES. CLINICAL PRACTICE
PATTERNS OUTSIDE THE UNITED STATES MAY DIFFER SUBSTANTIALLY FROM INFORMATION
SUPPLIED BY THE SERVICE. CLIENT ACKNOWLEDGES THAT IMO DOES NOT PROVIDE MEDICAL
SERVICES TO PATIENTS AND IS NOT ENGAGED IN THE PRACTICE OF MEDICINE. CLIENT
FURTHER ACKNOWLEDGES THAT ANY END-USER'S USE OF THE SOFTWARE DOES NOT ABSOLVE
THAT END-USER OF HIS/HER OBLIGATION TO EXERCISE INDEPENDENT MEDICAL JUDGMENT IN
RENDERING HEALTH CARE SERVICES TO PATIENTS. CLIENT ACKNOWLEDGES THAT THE
PROFESSIONAL DUTY TO THE PATIENT IN PROVIDING HEALTHCARE SERVICES LIES WITH THE
END-USER PROVIDING THE SERVICES, NOT WITH IMO.
D. Limitation
of Damages
IN NO CASE SHALL IMO OR CLIENT BE LIABLE FOR SPECIAL, PUNITIVE, EXEMPLARY, INDIRECT, INCIDENTAL
OR CONSEQUENTIAL DAMAGES, WHETHER SUCH DAMAGES ARE FORESEEABLE, AND
IRRESPECTIVE OF THE THEORY OR CAUSE OF ACTION UPON WHICH THE DAMAGES MIGHT BE
BASED. EXCEPT FOR VIOLATIONS OF SECTION 9A OR VIOLATIONS OF CONFIDENTIALITY,
EACH PARTY'S MAXIMUM LIABILITY TO THE OTHER SHALL BE LIMITED TO THE TOTAL
AMOUNTS PAID BY CLIENT TO IMO.
10. FORCE
MAJEURE
Except for obligations to pay
money, neither Client nor IMO shall have the responsibility for any delay or
failure of performance resulting from causes beyond its reasonable control and
without its fault or negligence. In such
event, the delayed party shall perform its obligations hereunder within a
reasonable time after the cause of the delay or failure has been remedied.
11. TERMINATION
A. The
Term shall be as set forth in Section 2 herein.
Either party may terminate this Agreement upon written notice to the
other in the event the other party breaches this Agreement and fails to cure
such breach within thirty (30) days after written notification of such breach
by the nonbreaching party. Upon termination of this Agreement for Client
breach or failure to renew, Client shall, within ten (10)
business days, return to IMO all documents, software and other materials or
deliverables (including all copies of manuals and demo products) received from
IMO or containing any of IMO’s products or trade secrets, in whole or in part
(and all copies thereof).
B.
In the event that IMO becomes bankrupt,
winds up, goes into receivership, or has a trustee appointed to dissolve its
assets, Client may terminate this Agreement immediately,
and is entitled to use the Service for the remainder of the term, in the manner
laid out in the Agreement, without additional charge. Client would not be
entitled to Updates, and all confidentiality and ownership clauses will survive
termination.
12.
DISPUTES
In
the event of any dispute under this Agreement the prevailing party shall be
entitled to recover its costs of litigation including its reasonable attorneys’
fees.
13. CONFIDENTIALITY
A.
Each party hereto shall hold, and cause its
respective officers, directors, employees, stockholders, parent entities,
permitted consultants and advisors (collectively, "Party Representatives")
to hold, in strict confidence all written documents and information concerning
the other party furnished to it by the other party or its Party Representatives
in connection with The Parties' respective duties and obligations contemplated
by this Agreement, except to the extent that such information can be shown to
have been (i) in the receiving party's possession
or was known by the receiving party prior to its receipt from the party to whom
the confidential information relates, (ii) in the public domain through no
fault of such party, (iii) later lawfully acquired by the party from a source
already in legitimate possession of such information, said source being other
than the party to whom it relates, or (iv) independently developed by or for
the receiving party without any use of the confidential information of the
disclosing party. Neither party shall release or disclose to any other person
or entity, or otherwise use, such information except strictly in connection
with The Parties' duties and obligations contemplated hereby. Each party shall notify the other promptly
concerning any law or order or other governmental agency having authority to
require disclosure of such confidential information, so that the disclosing
party can take appropriate action to protect such confidential information. Each party’s obligations under this Section 13 shall
survive the termination and/or the full performance of this Agreement.
B.
The fact that either
party has entered into agreements, including this Agreement, concerning the use
or license of any of its products shall not be deemed to place any confidential
information or trade secret of that party in the public domain or to cause the
same to be considered to be public knowledge.
The Parties acknowledge that nothing in this Section 13 shall
prohibit The Parties from disclosing the Integrated Service, associated End-User
documentation and sales and marketing materials to End-Users of the Integrated
Service as contemplated by this Agreement.
14. GENERAL
A. If any provision of this Agreement shall be deemed by a
court of competent jurisdiction to be unenforceable or illegal, then such
unenforceable or illegal provision shall be deemed stricken (but only to the
extent that, and in the locations where, such prohibition shall be
applicable). The remaining terms and
provisions of this Agreement shall remain in full force and effect provided
that The Parties agree that the Agreement can continue to be performed in
furtherance of The Parties’ objectives.
B. This
Agreement constitutes the entire agreement of Client and IMO with
respect to the subject matter hereof and supersedes and terminates all other
prior and contemporaneous agreements and understandings regarding the subject
matter hereof, except with respect to obligations that survive the termination
hereof. No provision of this Agreement
may be terminated, modified or waived unless such termination, modification or
waiver is set forth in a writing executed by authorized representatives of Client
and IMO.
C. This Agreement and the license issued hereunder shall be
binding upon and inure to the benefit of The Parties, their respective
successors and/or permitted assigns.
D. This Agreement shall in all respects be
governed by, construed, and interpreted in accordance with the laws of the
State of Illinois without regard to its conflict of law principles.
E. Each party represents and warrants that
it is not subject to, and will not assume (i) any obligation inconsistent with
its obligations hereunder and (ii) any restriction which is violated by any
disclosure of information it makes or receives hereunder.
F. Each party warrants and affirms that the
person signing this Agreement on behalf of that party is duly authorized and
empowered by that party to do so, and that such person has the right and the
authority to bind that party to this Agreement.
G.
The section headings throughout this
Agreement are for convenient reference only, and shall in no way be deemed to
limit, modify, or add to the interpretation, construction or meaning or any
provision of this Agreement.
H.
In performing their obligations hereunder, The
Parties are acting as separate and independent entities and neither party is an
agent or employee of the other party.
This Agreement shall not be interpreted so as to cause either party to
be responsible to any third party for the acts, omissions or products of the
other party.
I.
All notices and communications required or
permitted under this Agreement shall be in writing and any communication or
delivery hereunder shall be deemed to have been duly made if mailed by
registered or certified mail, postage prepaid, sent by nationally recognized
overnight delivery, or by telecopy, addressed as follows:
If
to Client:
___________________________
___________________________
___________________________
Attn: ______________________
Fax: ______________________
Phone:
_____________________
If to IMO, Inc.:
Intelligent Medical
Objects, Inc.
60
Revere Drive, Suite 360
Northbrook,
IL 60062
Attn.: CEO
With
copy to: Contracts Administrator
Fax: (847) 272-7968
Phone:
(847) 272-1242
Either
party may, by written notice so delivered to the other, change the address to
which delivery shall thereafter be made.
J.
Client agrees to comply fully with
all relevant export laws and regulations of the United States ("Export Laws")
to assure that neither the Service, nor any direct product thereof, are (a)
exported, directly or indirectly, in violation of Export Laws; or (b) are
intended to be used for any purposes prohibited by the Export Laws, including,
without limitation, nuclear, chemical, or biological weapons proliferation.
K.
IMO agrees to maintain insurance throughout
the term of this Agreement which is ordinary and reasonable for an organization
in the industry.
L.
No termination of this Agreement shall in
any way affect or impair the powers, obligations, duties, rights, indemnities,
liabilities, covenants, warranties, and/or representations of The Parties with
respect to times and/or events occurring prior to such termination, including
the obligation to make payments that arose prior to the termination date but
will not be paid until after the termination date.
M.
During the Agreement Term and for a period
of one year thereafter, Client will not solicit, i.e., offer
to employ, IMO's employees. This provision will not prevent or apply to a
general solicitation made by Client in a newspaper, through the
Internet, or in other similar media.
EXHIBIT A
LICENSED CONTENT – "The Service"
IMO® Vocabulary Portal
The IMO® Vocabulary Portal is a web-technology based
enhanced terminology service that provides standardized administrative and
reference codes based on user search term entry. The portal provides an
intelligent front end to the popular IMO® Problem ÍITЙ
knowledge database. The portal can be accessed over the Internet or from a
local LAN depending on the application and required response time. The portal
will provide coding from such standards including, but not limited to,
ICD-9-CM, SNOMED® CT and HCPCS.
IMO® Problem ÍITЙ
IMO® Problem ÍITЙ is a clinical diagnosis and problem
list vocabulary containing specialized terms for clinicians, coders, and
patients. Each term in the IMO® Problem ÍITЙ dictionary has a link to the
then-effective diagnosis coding system (e.g. in the United States, ICD-9-CM
through September 30, 2013 and ICD-10-CM on and after October 1, 2013, as such
dates may be officially changed by the U.S. Department for Health and Human
Services or such other applicable regulatory body). The 2011 version contains
approximately 195,000 terms and concepts, representing more than 17,000
ICD-9-CM codes. IMO® Problem ÍITЙ contains the expressions that
clinicians want to use for documenting encounter diagnoses, problem lists, and
past medical history. These characteristics represent a significant improvement
over other ICD-9 based vocabularies. IMO’s diagnosis and problem terminology
also contains maps to SNOMED® CT, MeSH, and the UMLS whenever possible, and is
represented in both hierarchical and semantic classifications. The patient
friendly terms are designed for use in patient health records to help patients
understand their conditions better and participate in their own health care.
Licensed Use
Client may implement the Service into Client’s eClinicalWorks’
Electronic Medical Record (“EMR”) solution for use by Client’s End-Users.
Client acknowledges that the current implementation level of the Service within
the eClinicalWorks EMR solution is limited to the Service ICD maps.
FEES AND PAYMENTS
1. FEES
A.
Provider
License Fees
Client will pay a license
fee of $65.00 per Provider
per year to IMO for the use of the Service by Client Providers.
Client current Provider count as of the Effective Date of the
Agreement will be provided by eClinicalWorks and will be displayed at the time
of determining method of payment and/or payment for the Service.
B.
IMO has the option to change the Client
fee schedule once annually with ninety (90) days prior written notice to Client.
IMO agrees that any such increase in the Client fee schedule shall not exceed
five (5) percent or the CPI whichever is greater. As used in this
paragraph, "CPI" means the Consumer Price Index for All Urban
Consumers, U.S. City Average, for All Items as published by the Bureau of Labor
Statistics of the Department of Labor.
2. PAYMENTS
A.
Within fifteen (15) days after the end of each
calendar quarter, Client will provide IMO with an aggregate number of Providers
of the Integrated Service through the IMO ONLINE website or via e-mail to
accounting@imo-online.com. IMO will invoice Client the Provider License Fees
for each reported Provider, which fees are payable by Client within thirty (30)
days.
B.
Any consulting service hours or travel related
expenses will be billed monthly and are due upon receipt.
C.
Client will be invoiced for any
appropriate sales tax for the State of Illinois unless tax exempt and a tax ID
number is provided to IMO. If Client
is required to pay a use tax in a state other than Illinois, Client
must accrue and pay this tax according to Client’s state’s requirements.
D.
If payments are overdue by more than thirty (30)
days, an interest fee of 1.5% per month (18% annual) will be applied to the
invoice.
3. DEFINITIONS
OF CONTACTS
Client Physician Champion - Client’s
Chief Medical Information Officer (CMIO).
Client Primary Clinical Contact
- The point person for IMO to contact regarding clinical content matters. This is often the same person as the
physician champion but may be different.
Client Primary Technical Contact - The
point person for IMO to contact regarding technical matters for Client’s
eClinicalWorks system.
Project Manager – The person
responsible for managing newly signed clients through the entire 8-12 week
Implementation Process.
Strategic Account Manager (SAM)
– The point person for IMO to contact from the moment Client is live with IMO
throughout the life of the Agreement.
Vocabulary Maintenance Website
Coordinator (VMWC) - The person responsible to send IMO term
requests. IMO will grant access to IMO’s
web-based Term Request site where the VMWC can make term requests for new (or
ask questions about existing) terms and mappings. The VMWC can also check on the status of the
request in real-time and interact with both the IMO knowledge staff as well as
the AHIMA staff whom IMO has partnered with to review and analyze IMO’s maps to
ICD-9-CM and ICD-10-CM.